EP Patent

EP1740163B1 — Mehrphasenpräparat zur kontrazeption auf der basis eines natürlichen estrogens

Assigned to Bayer Intellectual Property GmbH · Expires 2010-07-14 · 16y expired

What this patent protects

Patent listed against Natazia.

Drugs covered by this patent

Natazia (DIENOGEST) · Mochida Pharmaceutical Co., Ltd.

Patent Metadata

Patent number: EP1740163B1
Jurisdiction: EP
Classification: —
Expires: 2010-07-14
Drug substance claim: No
Drug product claim: No
Assignee: Bayer Intellectual Property GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.